Table 1 Summary of cases in which patients developed primary hepatic neuroendocrine carcinoma recurrence following surgical resection
From: Primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy: a case report
First author | Year | age | sex | Tumor size (cm) | Solitary (yes/no) | Treatment before surgery | Recurrence (months) | Site of recurrence | Treatment after recurrence | Survival (months) |
|---|---|---|---|---|---|---|---|---|---|---|
Hsueh | 1983 | 8 | F | 17 | Yes | Chemotherapy | None | None | None | 4 |
Zancotani | 1996 | 56 | M | 5 | Yes | None | 3 | Liver | None | 5 |
Pilichowska | 1999 | 57 | M | 8.2 | Yes | None | ND | Liver | None | 16 |
Ishida | 2003 | 72 | M | 3 | Yes | None | ND | ND | None | ND |
Garcia | 2006 | 50 | M | 5 | Yes | None | 4 | Liver | TACE, Chemotherapy | 16 |
Yang | 2009 | 65 | M | 7.5 | Yes | None | 3 | Liver | None | 12 |
56 | M | ND | No | None | None | None | ND | 36.9 | ||
68 | F | ND | No | None | None | None | ND | 18 | ||
51 | F | ND | No | Chemotherapy | 6.2 | ND | ND | 15.2 | ||
Akahoshi | 2010 | 64 | M | 1.5 | Yes | None | None | None | ND | 3 |
Huang | 2010 | 51 | M | ND | No | TACE | 48 | Liver | ND | 107 |
34 | M | ND | No | TACE | None | None | ND | 98 | ||
52 | F | ND | No | None | 5 | Liver | ND | 47 | ||
59 | M | ND | No | None | None | None | None | 34 | ||
54 | M | ND | No | None | None | None | None | 24 | ||
43 | M | ND | No | None | None | None | None | 15 | ||
50 | F | ND | No | None | 5 | Liver | ND | 14 | ||
37 | M | ND | No | None | 1 | Liver | PEIT | 13 | ||
58 | F | ND | No | None | 39 | ND | ND | 148 | ||
56 | F | ND | No | None | 5 | Liver | ND | 33 | ||
50 | M | ND | No | None | 3 | Liver | ND | 12 | ||
Chan Hyuk | 2012 | 51 | F | ND | No | Chemotherapy | None | ND | ND | 36.9 |
68 | F | ND | No | None | None | ND | ND | 18 | ||
51 | F | ND | No | Chemotherapy | 6.2 | ND | ND | 15.2 | ||
Shinkawa | 2013 | 73 | M | 5 | Yes | None | 4 | Bone, LN | ND | 6 |
Kim | 2013 | 67 | F | 9 | Yes | None | None | None | None | 3 |
Kano | 2014 | 73 | M | 3 | Yes | None | 6 | Liver | Chemotherapy | 10 |
Sotiropoul | 2014 | 19 | F | 27 | Yes | None | None | None | None | 24 |
Aboelene | 2014 | 51 | M | 20 | Yes | None | None | None | None | 6 |
Choi | 2016 | 72 | M | 2.2 | Yes | None | 6 | Liver | Chemotherapy | 4 |
Nakatake | 2017 | 62 | M | 5 | Yes | None | 3 | LN | Chemotherapy | 24 |
Harada | 2017 | 69 | F | 3.5 | Yes | None | 1 | Liver, Lung | Chemotherapy | 19 |
Xin | 2020 | 64 | F | 1.8 | Yes | None | ND | ND | None | 5 |
Yusuke | 2021 | 78 | M | 6.6 | Yes | None | 4 | LN | Chemotherapy | 4 |